Universe Pharmaceuticals INC Cash And Cash Equivalents At Carrying Value

Quick Answer

Universe Pharmaceuticals INC reported Cash And Cash Equivalents At Carrying Value of $8.08 million for the year ending 2021.

  • Universe Pharmaceuticals INC showed a decrease of -19.7% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
  • This data is from Universe Pharmaceuticals INC's annual report (Form 10-K), filed with the SEC on January 31, 2022.
  • XBRL data for this metric is available from 2018 to 2021 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2018 to 2021), Universe Pharmaceuticals INC's Cash And Cash Equivalents At Carrying Value has grown by 30.5%.
  • Historical annual values: Fiscal year 2021: $8.08 million | Fiscal year 2020: $10.06 million | Fiscal year 2019: $3.18 million | Fiscal year 2018: $6.19 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: